A cure for Alzheimer’s disease remains elusive

A cure for Alzheimer’s disease remains elusive

Billions of dollars have already been spent on the fight against the Alzheimer's disease, but a cure for the disease remains elusive.

No new treatment for Alzheimer’s has won the FDA’s approval since 2003, and clinical trials for the disease has 99 per cent failure rate. Merely five drugs have gained the FDA’s approval to treat the disease, and those drugs just alleviate symptoms.

In December last year, U.S. Congress passed a measure to set aside additional $3 billion to fund research of brain diseases and precision medicine to tackle disease like Alzheimer's over the next 10 years.

The effort, part of the 21st Century Cures Act, also offers prize money to egg on research and experiments on Alzheimer’s.

The Alzheimer's disease remains a major killer in the U.S., and the number of patients is on the rise. Some experts have warned that the disease will probably continue to grow as the U.S. population is aging rapidly.

Alzheimer’s is a progressive disease that destroys the patient’s memory and other key mental functions. It develops when brain cell connections degenerate and die, which destroys memory and other mental functions.

General: 
Companies: 

Popular Stories

Waymo seeks injunction against Otto and Uber

Google Inc. parent firm Alphabet-owned Waymo has... Read More

Great Barrier Reef experiencing coral bleaching for second consecutive year

The health of Australia’s Great Barrier Reef is in... Read More

Google Cloud acquires Kaggle

The Google Cloud Platform announced on Wednesday... Read More

NOAA budget cut could put lives at risk by hindering research: experts warn

As the Trump administration is reportedly mulling... Read More

Environmental pollution kills 1.7M children under 5 every year

A new report by the World Health Organization (WHO... Read More